{"cdcTestId":"2013-0186","testcaseName":"Dose 1 to dose 2 interval 6 months.  Series complete. ","vaccineGroup":"HepA","evaluationTestType":"Interval: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-02-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-04-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-04-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2017-11-15T07:00:47.066","generalDescription":"This test case describes when the second dose of the 2 dose Hep A vaccine is administered at least 6 months after the first dose, that no additional doses are recommended and that the series is considered complete.","changedInVersion":"1.0","reasonForChange":""}